Suppr超能文献

乳糜泻的新型治疗策略

Novel Therapeutic Strategies for Celiac Disease.

作者信息

Asri Nastaran, Rostami-Nejad Mohammad, Rezaei-Tavirani Mostafa, Razzaghi Mohammadreza, Asadzadeh-Aghdaei Hamid, Zali Mohammad Reza

机构信息

Gastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Proteomics Research Center, Faculty of Paramedical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

出版信息

Middle East J Dig Dis. 2020 Oct;12(4):229-237. doi: 10.34172/mejdd.2020.187.

Abstract

Celiac disease (CeD) is a widespread autoimmune enteropathy caused by dietary gluten peptides in genetically susceptible individuals, which includes a range of intestinal and extraintestinal manifestations. Currently, there is no effective treatment for CeD other than strict adherence to a gluten-free diet (GFD). However, persistent or frequent symptoms and also partial villus atrophy were observed in some patients with CeD due to intentional or inadvertent gluten exposure during the use of GFD. It means that GFD alone is not enough to control CeD symptoms and long-term complications. Accordingly, new therapeutic approaches for CeD treatment such as gluten proteolysis, removing gluten from the digestive tract, promoting tight junction assembly, inhibiting intestinal tissue transglutaminase 2, using probiotics, and developing immunotherapeutic methods have been proposed through different strategies. This review focused on discussing the novel therapeutic strategies for CeD management.

摘要

乳糜泻(CeD)是一种在遗传易感性个体中由膳食麸质肽引起的广泛存在的自身免疫性肠病,其包括一系列肠道和肠外表现。目前,除了严格遵循无麸质饮食(GFD)外,尚无治疗CeD的有效方法。然而,在一些CeD患者中,由于在使用GFD期间有意或无意接触麸质,观察到持续或频繁的症状以及部分绒毛萎缩。这意味着仅靠GFD不足以控制CeD症状和长期并发症。因此,已经通过不同策略提出了用于CeD治疗的新治疗方法,如麸质蛋白水解、从消化道去除麸质、促进紧密连接组装、抑制肠道组织转谷氨酰胺酶2、使用益生菌以及开发免疫治疗方法。本综述着重讨论CeD管理的新型治疗策略。

相似文献

1
Novel Therapeutic Strategies for Celiac Disease.
Middle East J Dig Dis. 2020 Oct;12(4):229-237. doi: 10.34172/mejdd.2020.187.
3
Novel Nondietary Therapies for Celiac Disease.
Cell Mol Gastroenterol Hepatol. 2019;8(3):335-345. doi: 10.1016/j.jcmgh.2019.04.017. Epub 2019 May 27.
4
Review article: therapeutic targets for the pharmacologic management of coeliac disease-the future beyond a gluten-free diet.
Aliment Pharmacol Ther. 2022 May;55(10):1277-1296. doi: 10.1111/apt.16846. Epub 2022 Feb 28.
6
Emerging Pharmaceutical Therapies to Address the Inadequacy of a Gluten-Free Diet for Celiac Disease.
Pharmaceuticals (Basel). 2023 Dec 20;17(1):4. doi: 10.3390/ph17010004.
7
New developments in celiac disease treatments.
Drug Discov Today. 2024 Sep;29(9):104113. doi: 10.1016/j.drudis.2024.104113. Epub 2024 Jul 25.
8
Evolving Therapy for Celiac Disease.
Front Pediatr. 2019 May 14;7:193. doi: 10.3389/fped.2019.00193. eCollection 2019.
9
Gluten Degrading Enzymes for Treatment of Celiac Disease.
Nutrients. 2020 Jul 15;12(7):2095. doi: 10.3390/nu12072095.
10
Nutritional Considerations in Celiac Disease and Non-Celiac Gluten/Wheat Sensitivity.
Nutrients. 2023 Mar 19;15(6):1475. doi: 10.3390/nu15061475.

引用本文的文献

1
The connection between fatty acids and inflammation in celiac disease; a deep exploring.
Tissue Barriers. 2025 Jan 2;13(1):2342619. doi: 10.1080/21688370.2024.2342619. Epub 2024 Apr 15.
4
The Effect of Gluten-Free Diet Duration on Body Mass Index of Iranian Patients with Celiac Disease.
Middle East J Dig Dis. 2022 Jul;14(3):323-329. doi: 10.34172/mejdd.2022.290. Epub 2022 Jul 30.
5
Introducing New Potential Biomarkers for Celiac Disease among the Genes Extracted from General Databases.
Middle East J Dig Dis. 2022 Apr;14(2):192-199. doi: 10.34172/mejdd.2022.272. Epub 2022 Apr 30.
6
Gene expression analysis of intestinal IL-8, IL-17 A and IL-10 in patients with celiac and inflammatory bowel diseases.
Mol Biol Rep. 2022 Jul;49(7):6085-6091. doi: 10.1007/s11033-022-07397-y. Epub 2022 May 8.
8
Screening of Altered Metabolites and Metabolic Pathways in Celiac Disease Using NMR Spectroscopy.
Biomed Res Int. 2021 Nov 15;2021:1798783. doi: 10.1155/2021/1798783. eCollection 2021.

本文引用的文献

3
The anti-inflammatory potential of cefazolin as common gamma chain cytokine inhibitor.
Sci Rep. 2020 Feb 19;10(1):2886. doi: 10.1038/s41598-020-59798-3.
4
Gliadin Nanoparticles Induce Immune Tolerance to Gliadin in Mouse Models of Celiac Disease.
Gastroenterology. 2020 May;158(6):1667-1681.e12. doi: 10.1053/j.gastro.2020.01.045. Epub 2020 Feb 4.
5
Suppressive Mechanisms Induced by Tregs in Celiac Disease.
Iran Biomed J. 2020 May;24(3):140-7. doi: 10.29252/ibj.24.3.140. Epub 2020 Jan 18.
6
Evolving Therapy for Celiac Disease.
Front Pediatr. 2019 May 14;7:193. doi: 10.3389/fped.2019.00193. eCollection 2019.
7
Novel Nondietary Therapies for Celiac Disease.
Cell Mol Gastroenterol Hepatol. 2019;8(3):335-345. doi: 10.1016/j.jcmgh.2019.04.017. Epub 2019 May 27.
9
Celiac Disease: A Review of Current Concepts in Pathogenesis, Prevention, and Novel Therapies.
Front Pediatr. 2018 Nov 21;6:350. doi: 10.3389/fped.2018.00350. eCollection 2018.
10
Probiotics in Celiac Disease.
Nutrients. 2018 Nov 23;10(12):1824. doi: 10.3390/nu10121824.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验